PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 19.11.2019 at 4:00 PM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (US20130065956) Composition and/or method for preventing onset and/or recurrence of cardiovascular events

Office : United States of America
Application Number: 13672405 Application Date: 08.11.2012
Publication Number: 20130065956 Publication Date: 14.03.2013
Grant Number: 09198892 Grant Date: 01.12.2015
Publication Kind : B2
IPC:
A61K 31/232
A61K 9/48
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
21
Esters, e.g. nitroglycerine, selenocyanates
215
of carboxylic acids
22
of acyclic acids, e.g. pravastatin
23
of acids having a carboxyl group bound to a chain of seven or more carbon atoms
232
having three or more double bonds, e.g. etretinate
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
48
Preparations in capsules, e.g. of gelatin, of chocolate
Applicants: MOCHIDA PHARMACEUTICAL CO., LTD.
Inventors: Mitsuhiro Yokoyama
Hideki Origasa
Masunori Matsuzaki
Yuji Matsuzawa
Yasushi Saito
Yuichi Ishikawa
Shinichi Oikawa
Jun Sasaki
Hitoshi Hishida
Hiroshige Itakura
Toru Kita
Akira Kitabatake
Noriaki Nakaya
Toshiie Sakata
Kazuyuki Shimada
Kunio Shirato
Agents: Birch, Stewart, Kolasch & Birch, LLP
Priority Data: 2005-200503 08.07.2005 JP
Title: (EN) Composition and/or method for preventing onset and/or recurrence of cardiovascular events
Abstract:
(EN)

Provided are composition and/or methods useful in preventing onset and/or recurrence of cardiovascular events, especially in patients who have escaped the unstable period after cardiovascular angioplasty or in hyperlipidemia patients who have been treated with HMG-CoA RI.


Also published as:
NO20065384EP1790339BRPI0613704-0JP2007039452JP2008050367US20070021504
JP2012193211CN101217952CN102526733CA2570763ES2489741KR1020130137055
US20160045469WO/2007/007686